Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Revenue (2018 - 2025)

Lipocine (LPCN) has disclosed Revenue for 9 consecutive years, with $114574.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue changed N/A year-over-year to $114574.0, compared with a TTM value of $4.3 million through Sep 2025, down 41.43%, and an annual FY2024 reading of $11.2 million, up 292.8% over the prior year.
  • Revenue was $114574.0 for Q3 2025 at Lipocine, down from $622849.0 in the prior quarter.
  • Across five years, Revenue topped out at $16.1 million in Q4 2021 and bottomed at -$326168.0 in Q4 2023.
  • Average Revenue over 5 years is $2.2 million, with a median of $104219.0 recorded in 2025.
  • The sharpest move saw Revenue surged 19926.51% in 2021, then tumbled 98.77% in 2025.
  • Year by year, Revenue stood at $16.1 million in 2021, then plummeted by 96.89% to $500000.0 in 2022, then tumbled by 165.23% to -$326168.0 in 2023, then surged by 1170.43% to $3.5 million in 2024, then crashed by 96.72% to $114574.0 in 2025.
  • Business Quant data shows Revenue for LPCN at $114574.0 in Q3 2025, $622849.0 in Q2 2025, and $93864.0 in Q1 2025.